[1] Sweetman and S. C. Martindale, “The Complete Drug Reference,” 36th Edition, 2009.
[2] M. J. Oneil, A. Smith and P. E. Heckelman, “The Merck Index,” 13th Edition, Merck & Co. Inc, White House Station, 2001.
[3] G. Khaksa and N. Udupa, “Rapid and Sensitive Method for Determination of Nimesulide in Human Plasma by High-Performance Liquid Chromatography,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 727, No. 1-2, 1999, pp. 241-244. doi:10.1016/S0378-4347(98)00567-2
[4] D. J. Jaworowicz, M. T. Filipowski and K. M. K. Boje, “Improved High Performance Liquid Chromatographic Assay for Nimesulide,” Journal of Chromatography B, Vol. 723, 1999, pp. 293-299. doi:10.1016/S0378-4347(98)00559-3
[5] S. S. Zarapkar, N. P. Bhandari and U. P. Halkar, “Simultaneous Determination of Nimesulide and Chlorzoxazone in Pharmaceutical Dosage by RP HPLC,” Indian Drugs, Vol. 37, 2000, p. 467.
[6] B. Raman and D. Patil, “RPHPLC for the Simultaneous Estimation of Tinidazole and Nimesulide in Tablets,” Indian Drugs, Vol. 39, 2002, pp. 392-394.
[7] P. Kovaikova, M. Mokry and J. Klime, “Photochemical Stability of Nimesulide,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 31, No. 4, 2003, pp. 827-832. doi:10.1016/S0731-7085(02)00659-3
[8] B. S. Nagaralli, J. G. Seetharamappa, B. G. Gowda and M. B. Melwanki, “High Performance Liquid Chromatography Method for the Determination of Nimesulide in Pharmaceutical Preparations,” Journal of Analytical Chemistry, Vol. 58, No. 8, 2003, pp. 873-875. doi:10.1023/A:1025095829622
[9] R. Nageswara Rao , S. Meena , D. Nagaraju , A. Raghu Ram Rao, “Development and Validation of a Reversed- phase Liquid Chromatographic Method for Separation and Simultaneous Determination of COX-2 Inhibitors in Pharmaceuticals and Its Application to Biological Fluids,” Biomedical Chromatography, Vol. 19, No. 5, 2004, pp. 362-368. doi:10.1002/bmc.458
[10] P. D. Tzanavaras and D. G. Themelis, “Validated High-Throughput HPLC Assay for Nimesulide Using a Short Monolithic Column,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 43, No. 4, 2006, pp. 1483- 1487. doi:10.1016/j.jpba.2006.10.014
[11] H. Nimje, S. P. Wate and D. P. Dharkar, “Determination of Nimesulide and Tizanidine in Tablets,” Indian Journal of Pharmaceutical Sciences, Vol. 69, No. 2, 2007, pp. 281-283. doi:10.4103/0250-474X.33158
[12] M. Mokry, J. Klimes and J. Pechova, “HPLC Analysis of a Syrup Containing Nimesulide and Its Hydrolytic Degradation Product,” Chemical Papers, Vol. 64, 2010, pp. 405-408. doi:10.2478/s11696-010-0001-2
[13] F. A. Elbarbry, M. M. Mabrouk and M. A. El-Dway, “Determination of the Analgesic Components of Spasmomigraine Tablet by Liquid Chromatography with Ultraviolet Detection,” Journal of AOAC International, Vol. 90, No. 1, 2007, pp. 94-101.
[14] P. S. Barde, A. Y. Desai, S. M. N. Roy and V. V. Vaidya, “Simultaneous RP HPLC Determination of Camylofin Dihydrochloride in Pharmaceutical Preparation,” TSI Journal, Vol. 7, No. 10, 2008.
[15] R. R. Singh, M. V. Rathnam and R. Vegesna, “Simultaneous RP HPLC Determination of Camylofin Dihydrochloride and Paracetamol in Pharmaceutical Preparations,” TSI Journal, Vol. 7, No. 11, 2008.
[16] M. V. Rathnam and R. R. Singh, “Simultaneous RP HPLC Determination of Camylofin Dihydrochloride and Diclofenac Potassium in Pharmaceutical Preparations,” Pharm Anal Acta, Vol. 1, No. 2, 2010, p. 1000108. doi:10.4172/2153-2435.1000108
[17] E. Crombeza, W. Van Den Bosschea and P. De Moerloosea, “Gas Chromatographic Determination of Camylofine Dihydrochloride in Tablets and Suppositories,” Journal of Chromatography A, Vol. 117, No. 1, 1976, pp 161-166. doi:10.1016/S0021-9673(00)81077-8
[18] L. R. Snyder, J. J. Kirland and J. L. Glajch, “Practical HPLC Method Development,” 2nd Edition, John Wiley and sons, Inc., Hokoben, 1997.
[19] ICH, “Validation of Analytical Procedures; Text and Methodology,” International Conference on Harmonization Guidance Documents, Q2 (R1), 2005.
[20] ICH, “Photo Stability Testing of New Drugs Substances and Products,” International Conference on Harmonization Guidance Documents, Q1B, 2005.
[21] ICH, “Stability Testing of New Drug Substances and Products,” International Conference on Harmonization Guidance Documents, Q1A (R20), 2005.